
Shares of Longevity Health Holdings Inc (NASDAQ:XAGE) surged on Tuesday afternoon following the announcement of its definitive merger agreement with plasma collection leader True Health Inc.
What To Know: The all-stock transaction will see the combined entity continue trading on Nasdaq under the XAGE ticker. This strategic pivot follows Longevity Health’s mutual termination of a previously announced merger with 20/20 BioLabs. The new deal with True Health, which operates as THPlasma, aims to leverage plasma synergies to drive bioaesthetic innovation.